Aspirin/Atorvastatin/Metoprolol Succinate/Ramipril

阿司匹林/阿托伐他汀/琥珀酸美托洛尔/雷米普利

Report date: 2022/04/07 09:13:30

Base Information

Drug NameAspirin/Atorvastatin/Metoprolol Succinate/Ramipril
Drug Alias Name阿司匹林阿托伐他汀琥珀酸美托洛尔雷米普利acetylsalicylic acid/Atorvastatin/Metoprolol Succinate/Ramipril乙酰水杨酸/阿托伐他汀/琥珀酸美托洛尔/雷米普利Atorvastatin Calcium Hydrate/Metoprolol Succinate/Ramipril/AspirinAtorvastatin/Metoprolol Succinate/Ramipril/Aspirin +[9] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAngiotensin-converting enzyme inhibitorsHMG-CoA reductase inhibitors +[4] 
TargetsAngiotensin-converting enzymeBeta-1 adrenergic receptorHMG-CoA reductase +[4] 
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsCardiovascular Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2007/01/01
Country/TerritoryIndia
CombinationsYes Metoprolol SuccinateRamiprilAspirin
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTorrent Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTorrent Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeC10BA
Related LinksN/A